Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT02442466
What this trial is testing

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

Who this might be right for
Melanoma
MelCure SA 5
Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Testing effectiveness (Phase 2)Study completedNCT00003646
What this trial is testing

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical 78
Testing effectiveness (Phase 2)Study completedNCT00651703
What this trial is testing

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG 21
Testing effectiveness (Phase 2)WithdrawnNCT02763761
What this trial is testing

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Who this might be right for
Renal Cell CarcinomaMelanomaLung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00003346
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 80
Early research (Phase 1)Study completedNCT03864042
What this trial is testing

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Melanoma
Pfizer 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07747935
What this trial is testing

Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
ReBio Pharma 30
Testing effectiveness (Phase 2)Ended earlyNCT01973608
What this trial is testing

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Who this might be right for
Melanoma
EMD Serono 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585
What this trial is testing

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT02771340
What this trial is testing

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

Who this might be right for
Uveal MelanomaChoroid Neoplasm
Iconic Therapeutics, Inc. 10
Early research (Phase 1)Study completedNCT00003690
What this trial is testing

Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerMelanoma (Skin)Prostate Cancer+1 more
Mayo Clinic 48
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Testing effectiveness (Phase 2)Study completedNCT01037127
What this trial is testing

Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor

Who this might be right for
Cancer
GlaxoSmithKline 97
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Not applicableLooking for participantsNCT07138222
What this trial is testing

IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Peter MacCallum Cancer Centre, Australia 80
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Not applicableNo Longer AvailableNCT03311542
What this trial is testing

Expanded Access for Pembrolizumab (MK-3475)

Who this might be right for
Melanoma (Skin)Melanoma RecurrentGlioblastoma Multiforme+2 more
Center Trials & Treatment
Testing effectiveness (Phase 2)Ended earlyNCT01200342
What this trial is testing

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 7
Next Page